Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Imperial College Healthcare NHS Trust
St Mary's Hospital, Praed Street
London
W21NY
UK
Contact person: Lee Matthews
E-mail: lee.matthews2@nhs.net
NUTS: UKI33
Internet address(es)
Main address: https://www.imperial.nhs.uk
Address of the buyer profile: https://www.imperial.nhs.uk
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
http://health.atamis.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
http://health.atamis.co.uk
Tenders or requests to participate must be sent to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
http://health.atamis.co.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Provision of a Chemotherapy ePrescribing System and Support Services
Reference number: C50552
II.1.2) Main CPV code
85149000
II.1.3) Type of contract
Services
II.1.4) Short description
Provision of a Chemotherapy ePrescribing System and Support Services for and on behalf of (1) Imperial College Healthcare NHS Trust, (2) Chelsea and Westminster Hospital NHS Foundation Trust, (3) London North West University Healthcare NHS Trust and (4) The Hillingdon Hospitals NHS Foundation Trust
II.1.5) Estimated total value
Value excluding VAT:
1 900 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
48000000
II.2.3) Place of performance
NUTS code:
UKI32
Main site or place of performance:
(1) Imperial College Healthcare NHS Trust, (2) Chelsea and Westminster Hospital NHS Foundation Trust, (3) London North West University Healthcare NHS Trust and (4) The Hillingdon Hospitals NHS Foundation Trust
II.2.4) Description of the procurement
Imperial College Healthcare NHS Trust, acting as lead Authority for (1) Imperial College Healthcare NHS Trust, (2) Chelsea and Westminster Hospital NHS Foundation Trust, (3) London North West University Healthcare NHS Trust and (4) The Hillingdon Hospitals NHS Foundation Trust, requires a single, specialist Chemotherapy Electronic Prescribing System for cancer services for use across the North West London (NWL) Integrated Care System (ICS).The solution needs to have the capability of interfacing with numerous IT systems within each participating Trust to provide both clinical and administrative functions, with the ability to support services that are located across multiple sites, both in acute and community/outpatient settings.The supplier will be contracted for the supply and maintenance of a Chemotherapy Electronic Prescribing System which must include Haemato-oncology, Solid Tumours and Paediatric Oncology.The successful solution must provide the following key functionality: 1. Provision of specialist chemotherapy e-Prescribing providing a complete end-to-end chemotherapy prescribing solution including predefined regimens, prescribing, scheduling, dispensing, through to chemotherapy administration and reporting. 2. The ability to integrate with other software solutions both internal and external to the participating NWL ICS Trusts. In particular, with the increasing integration of cytotoxic treatment and radiotherapy, integrate with radiotherapy treatment and verification systems to support chemo-radiation regimens. The integration must be capable of two-way communication with other Trust solutions ensuring critical clinical information is shared. 3. The ability to accommodate all of the participating NWL ICS Trust’s cancer patients for the duration of the contract including any possible future service expansion requirements. Automatic dose calculations, allergy & sensitivity alerting, decision support linked to pathology & toxicity, drug-to-drug interaction support, and bar-coded wristband & drug scanning. 4. Enable the participating NWL ICS Trusts to analyse and audit all clinical processes of all participating Trusts chemotherapy prescribing activities and be fully compliant with all national reporting requirements including SACT (NHS Standards - Appendix 2) 5. The successful solution must provide integration capability to integrate with each participating NWL ICS Trusts pre-defined application currently in use, as part of in-flight projects and new projects. The main term of the contract shall be 5 years with the option, at the Authority's sole discretion, for 2 + 2 + 1 year contract extensions.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
1 900 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: Yes
Description of renewals:
Provision to extend the contract, at the Authority's sole discretion, for a further 2 x 2 x 1 year periods. The minimum contract term, subject to termination options, shall be 5 years and maximum contract duration shall therefore be 10 years.
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:
The Authority's ITT cover conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
III.2.2) Contract performance conditions
Please refer to the Authority's ITT
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2021/S 000-012111
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
29/11/2021
Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until:
01/04/2022
IV.2.7) Conditions for opening of tenders
Date:
29/11/2021
Local time: 12:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
Yes
VI.4) Procedures for review
VI.4.1) Review body
The High Court
Strand
London
WC2A 2LL
UK
E-mail: generaloffice@administrativecourtoffice.justice.gov.uk
Internet address(es)
URL: https://www.gov.uk/courts-tribunals
VI.4.4) Service from which information about the review procedure may be obtained
The High Court
Strand
London
WC2A 2LL
UK
E-mail: generaloffice@administrativecourtoffice.justice.gov.uk
Internet address(es)
URL: https://www.gov.uk/courts-tribunals
VI.5) Date of dispatch of this notice
29/10/2021